^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | everolimus (mTOR inhibitor) + letrozole (Aromatase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Endometrial cancer: Systemic Therapy for Endometrial Carcinoma...Recurrent, Metastatic or High-risk Disease…Other recommended regimens…Everolimus/letrozole
